Our analyses of GO and KEGG pathway enrichment revealed that most of the identified human transcripts were involved in metabolic pathway and MAPK1/MAPK3 signaling, which is a critical biological process controlling the pathogenesis and development of T2DM, suggesting that mRNA m6A methylation plays a crucial role in T2DM. This evidence concerns the gene MAPK3 and type 2 diabetes mellitus.